|
Volumn 27, Issue 13, 2000, Pages 2048-2058
|
Latest progress on chemotherapy for advanced gastric cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
CAMPTOTHECIN;
CF REGIMEN;
CISPLATIN;
DOCETAXEL;
DRUG DERIVATIVE;
FLUOROURACIL;
IRINOTECAN;
OXONIC ACID;
PACLITAXEL;
PYRIDINE DERIVATIVE;
S 1 (COMBINATION);
TAXOID;
TEGAFUR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
HUMAN;
MORTALITY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
STOMACH TUMOR;
SURVIVAL RATE;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FLUOROURACIL;
HUMANS;
OXONIC ACID;
PACLITAXEL;
PYRIDINES;
RANDOMIZED CONTROLLED TRIALS;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TAXOIDS;
TEGAFUR;
|
EID: 0034321673
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (6)
|
References (65)
|